Intuit CEO Discusses AI Agent Strategy TD Cowen Maintains Buy Rating on Snowflake Ahead of Q1 Earnings Report Japan China Trade Chiefs Hold First Direct Talks at APEC Since Escalated Trade Dispute Post Oak Group Identifies Middle Market as Key Growth Driver for 2026 MA FTSE Index Rejig Adds Tata Capital Lenskart and Groww Among Six Stocks to Global Indices Trump Postpones AI Executive Order Signing Cites Concerns Over Potential Blocking Effects KLIC Q1 2026 Earnings EPS Surges Past Estimates Stock Advances BWNB Q1 2026 Earnings Significant EPS Miss Triggers Negative Market Response PSN Q1 2026 Earnings Strong EPS Surprise Drives Positive Stock Reaction Holley Inc Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Movement Ameresco Inc AMRC Q1 2026 Earnings EPS Misses Estimates Amid Challenging Quarter Alcon ALC Q1 2026 Earnings EPS Beats Estimates as Surgical and Vision Care Segments Drive Profitability Big Tree Cloud Holdings DSY Rallies 737 Testing Resistance After Support Hold MoonLake Immunotherapeutics MLTX Edges Lower as Stock Tests Support Near 1728 MPLX LP MPLX Holds Near 56 as Distribution Yield Remains a Key Draw Despite MidWeek Dip Oppenheimer Holdings OPY Holds Steady Near 94 as Trading Volume Signals Caution First US Bancshares Inc FUSB Holds Steady at 160 Consolidation Phase Ahead AnheuserBusch InBev Shares Decline as Sales Miss Analyst Estimates Everest Group EG Q1 2026 Earnings EPS Surges Past Estimates on Strong Underwriting ADMA Biologics Slides 109 Key Support Levels in Focus Amid Biotech Headwinds EXC Q1 2026 Earnings EPS Beat Driven by Operational Strength and Favorable Weather ENIC Q4 2025 Earnings EPS Beat Surprises Market Despite Stock Decline HWCPZ Q1 2026 Earnings Slight EPS Beat Highlights Steady Performance AEE Q1 2026 Earnings EPS Beat Driven by Operational Efficiency and Rate Base Growth APO Q1 2026 Earnings EPS Slightly Misses Estimate Stock Holds Steady EIKN Q1 2026 Earnings PreRevenue Biotech Misses EPS Estimates Stock Slips SKYE Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Continues Development